The headline of this article — “Rosemary Kennedy Was Lobotomized at 23” — is accurate on the basis of the available evidence. The discrepancy in the JFK archives blog is likely an arithmetic error or a loose rounding rather than evidence of a different surgery date. No source examined for this article places the lobotomy before September 1941.
This is not a minor editorial point. Rosemary’s age at the time of the surgery matters to the story because it establishes that she was a full adult — not a teenager, not a child, but a twenty-three-year-old woman with her own history, her own demonstrated capabilities, her own relationship to the world. Whatever remaining questions there might be about the appropriate decision for a disabled child or adolescent, they are not the questions that apply to the decision made about Rosemary Kennedy in November 1941. She was an adult, and she was not asked.
What Changed in Medicine After the Lobotomy Era
The medical reckoning with lobotomy that unfolded in the 1950s and 1960s was not primarily driven by dramatic revelations or individual whistleblowers. It was driven by the same mechanisms that usually produce medical progress: accumulating evidence, new alternatives, and the eventual consensus of a professional community confronting its own earlier mistakes.
The introduction of chlorpromazine (Thorazine) in 1954 was the most important single factor. For the first time, psychiatrists had a medication that demonstrably reduced the symptoms of severe psychosis — the hallucinations, delusions, and disorganized thinking that had made severe schizophrenia essentially unmanageable in any setting. The availability of antipsychotic medication removed the primary justification for lobotomy as a treatment of last resort, because there was now another last resort that did not require permanently damaging the frontal lobes.